MDPI and ACS Style
Masisi, B.K.; El Ansari, R.; Alfarsi, L.; Fakroun, A.; Erkan, B.; Ibrahim, A.; Toss, M.; Ellis, I.O.; Rakha, E.A.; Green, A.R.
Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with Chemotherapy. Cancers 2024, 16, 1949.
https://doi.org/10.3390/cancers16111949
AMA Style
Masisi BK, El Ansari R, Alfarsi L, Fakroun A, Erkan B, Ibrahim A, Toss M, Ellis IO, Rakha EA, Green AR.
Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with Chemotherapy. Cancers. 2024; 16(11):1949.
https://doi.org/10.3390/cancers16111949
Chicago/Turabian Style
Masisi, Brendah K., Rokaya El Ansari, Lutfi Alfarsi, Ali Fakroun, Busra Erkan, Asmaa Ibrahim, Michael Toss, Ian O. Ellis, Emad A. Rakha, and Andrew R. Green.
2024. "Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with Chemotherapy" Cancers 16, no. 11: 1949.
https://doi.org/10.3390/cancers16111949